A Pivotal Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 250/50 Inhalation Powder/GSK in Healthy Volunteers
Clinical trial NCT04466176 · COMPLETED
Trial details
- NCT number
- NCT04466176
- Sponsor
- Respirent Pharmaceuticals Co Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-01
- Primary completion
- 2020-08-04
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.